| Bioactivity | sPLA2 inhibitor 3 (Compound 6c) is a potent α-glucosidase inhibitor (IC50 = 0.0953 µM). sPLA2 inhibitor 3 can be used for the research of diabetes[1]. |
| Formula | C22H16F6N6O4S2 |
| Molar Mass | 606.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Alasmary FAS, et al. Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes. J Enzyme Inhib Med Chem. 2024 Dec;39(1):2395985. |